ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1280

The Role of Sphingosine-1-Phosphate Receptor 3 Signaling in Murine Collagen-Induced Arthiritis

Hidetake Nagahara1, Masataka Kohno1, Ken Murakami1, Aihiro Yamamoto1, Takahiro Seno1, Wataru Fujii1, Kazuki Fujioka1, Yuji Kukida1, Ryo Oda2, Hiroyoshi Fujiwara2 and Yutaka Kawahito1, 1Department of Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, kyoto, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Collagen, Lipids, mouse model and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Sphingolipids represent a major class of lipids that are ubiquitously expressed in eukaryotic cell membranes. Through the interaction with a family of five G-protein-coupled receptors (S1P1–5), sphingosine-1-phosphate (S1P) triggers diverse cellular responses, including cytoskeletal changes, proliferation, and migration. The importance of S1P in inflammation has been extensively demonstrated. Some reports have shown that elevated S1P level and S1P1, 3 expression are detected in RA synovium, and S1P signaling via S1P1 promotes synoviocyte proliferation. It is suggested that S1P is an important inflammatory mediator in the pathogenesis of arthiritis, but the role of S1P3 in the pathogenesis of arthiritis are poorly understood. Thus, we examine the role of S1P3 receptor signaling in the development of collagen-induced arthritis (CIA) in murine.

Methods:

Wild-type(WT) and S1P3-deficient(S1P3-/-) mice backcrossed more than 9 generations to DBA/1J mice were immunized with bovine type II collagen (CII), and the severity of arthritis was assessed over time. The severity was assessed using an established semiquantitative scoring system of 0–4: 0=normal, 1=mild, 2=moderate, 3=severe and 4=most severe. The cumulative score for all four paws of each mouse (the maximum score is 16) was used as the arthritis score to represent overall disease severity and progression in an animal. Mice were sacrificed on the 42nd day and their paws were fixed in 4% buffered formaldehyde. Paraffin sections of paws stained with hematoxylin and eosin (H&E) were systematically scanned in a microscope and histopathological changes were scored based on cell infiltration, cartilage destruction and bone erosion parameters.

Results:

S1P3-/- mice showed signiflcantIy lower arthritis severity score compared with WT mice (P < 0.05). Histopathological evaluation of paws obtained on day 42 showed marked reductions in synovial inflammation, cartilage destruction and bone erosion parameters in S1P3-/-mice compared with WT mice (P < 0.05).

Conclusion:

These results indicate that S1P3 receptor signaling plays an important role in the development of murine collagen-induced arthritis model.This pathway could be a therapeutic target for rheumatoid arthritis, although further investigations are required to elucidate the mechanism via S1P3 receptor signaling.


Disclosure:

H. Nagahara,
None;

M. Kohno,
None;

K. Murakami,
None;

A. Yamamoto,
None;

T. Seno,
None;

W. Fujii,
None;

K. Fujioka,
None;

Y. Kukida,
None;

R. Oda,
None;

H. Fujiwara,
None;

Y. Kawahito,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-sphingosine-1-phosphate-receptor-3-signaling-in-murine-collagen-induced-arthiritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology